What this means
Researchers plan to test whether royal jelly affects inflammation and aging cells in people on dialysis. No results have been reported yet, so we do not know if it works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18–70
- Where
- 1 site
The science
- Registered title
- Effects of Royal Jelly Supplementation in Chronic Kidney Disease
- Trial ID
- NCT06438445 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Kidney Failure, Chronic, Oxidative Stress, Hemodialysis
- What is tested
- Real Jelly, Placebo
- Sponsor
- Universidade Federal Fluminense
- Ages
- 18 Years to 70 Years
- Dates
- First posted May 31, 2024 · updated May 18, 2026
Registry summary
The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).
Sites (1)
- Denise Mafra, Rio de Janeiro, Rio de Janeiro, Brazil